The DRD2 rs1076560 polymorphism and schizophrenia-related intermediate phenotypes: A systematic review and meta-analysis

Neurosci Biobehav Rev. 2017 Mar;74(Pt A):214-224. doi: 10.1016/j.neubiorev.2017.01.006. Epub 2017 Jan 16.


Intermediate phenotypes may contribute to elucidate the genetic determinants of schizophrenia. A regulatory dopamine 2-receptor gene (DRD2) polymorphism (rs1076560; G>T) has been identified as a genetic risk factor for schizophrenia. Studies report conflicting results on its involvement in schizophrenia intermediate phenotypes and no systematic review on this topic has been published. Therefore, we aimed to assess whether this polymorphism is implicated in schizophrenia intermediate phenotypes by performing a systematic review and meta-analysis. Alternative allele carrier status negatively affected all intermediate phenotypes except for brain morphology, for which inconsistent genotype effects were found. Specifically, alternative allele carriers showed inefficient brain recruitment in healthy subjects and decreased brain recruitment in schizophrenia patients. Finally, significant results of the meta-analysis on functional magnetic resonance imaging in healthy subjects pinpointed rs1076560-associated brain regions, in particular the fronto-striatal network. To increase homogeneity and thus improve comparability in future genetic studies investigating SCZ intermediate phenotypes, we highlight methodological caveats and provide suggestions to circumvent such pitfalls.

Keywords: DRD2; Functional magnetic resonance imaging (fMRI); Meta-analysis; Schizophrenia; Systematic review; rs1076560.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Genotype
  • Humans
  • Phenotype
  • Polymorphism, Single Nucleotide*
  • Receptors, Dopamine D2 / genetics*
  • Schizophrenia*


  • DRD2 protein, human
  • Receptors, Dopamine D2